NCT07086092

Brief Summary

This study aim to retrospectively investigate the effects of the magnesium, vitamin D, and uric acid serum markers on motor recovery and ambulation in post-stroke patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
257

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2025

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

July 18, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 25, 2025

Completed
Last Updated

July 29, 2025

Status Verified

July 1, 2025

Enrollment Period

Same day

First QC Date

July 18, 2025

Last Update Submit

July 25, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Serum magnesium levels

    Serum magnesium levels measured before the patients' rehabilitation will be obtained from past medical records.

    Before treatment

  • Serum uric acid levels

    Serum uric acid levels measured before the patients' rehabilitation will be obtained from past medical records.

    Before treatment

  • Serum vitamin D levels

    Serum vitamin D levels measured before the patients' rehabilitation will be obtained from past medical records.

    Before treatment

  • Brunnstrom Motor Recovery Stage

    Brunnstrom stages is a scale used to assess motor recovery after a stroke, which is expressed using values between 1 and 6. The higher the value on this scale, the higher would be the recovery. Brunnstrom Motor Recovery Stages measured before the patients' rehabilitation will be obtained from past medical records.

    Before treatment

  • Functional Ambulation Classification

    Functional Ambulation Classification is a 6-point functional walking test that evaluates ambulation ability and determines the amount of human support required by patients while walking, regardless of whether they use a personal assistive device. A score of 0 indicates that the patient has a dysfunctional ambulation A score of 5 denotes independent ambulation on any surface. Functional Ambulation Classification Stages measured before the patients' rehabilitation will be obtained from past medical records.

    Before treatment

Interventions

Serum magnesium, uric acid, and vitamin D levels, as well as motor recovery and ambulation levels, measured during the patients' rehabilitation stay will be obtained from past medical records.

Eligibility Criteria

Age30 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who have had a stroke for the first time and are hospitalized in the rehabilitation ward for rehabilitation purposes.

You may qualify if:

  • Patients who had a single stroke between 2019 and 2024
  • Patients who were admitted to the rehabilitation ward and had their serum vitamin D, magnesium, and uric acid levels measured
  • Patients whose functional ambulation scale scores and Brunnstrom motor recovery stages were recorded

You may not qualify if:

  • Patients with other neurological diseases
  • Patients with multiple strokes
  • Patients with gout, renal failure, or hyperparathyroidism

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Abant Izzet Baysal University

Bolu, 14100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Stroke

Interventions

Uric Acid

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

XanthinesAlkaloidsHeterocyclic CompoundsPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

July 18, 2025

First Posted

July 25, 2025

Study Start

July 15, 2025

Primary Completion

July 15, 2025

Study Completion

July 15, 2025

Last Updated

July 29, 2025

Record last verified: 2025-07

Locations